Skip to main content

Table 3 Descriptive statistics for the levels of matrix metalloproteinases (MMP–2, MMP–9), their inhibitors (TIMP-1, TIMP-2) and adiponectin at three time points, i.e. before radioiodine treatment (RIT), visit 1 (V1), seven days post RIT, visit 2 (V2), and two-three months post RIT, visit 3 (V3), p-value for the Friedman ANOVA test, Group 2, n=20

From: In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis

  Visits Mean Med Min Max SD SEM p-value
MMP-2 [ng/ml] V1 356 358.0 243.9 488.0 73.2 16.8 0.24
V2 349 348.8 221.8 470.3 63.3 14.9
V3 362 373.1 283.2 449.2 54.0 13.5
MMP-9 [ng/ml] V1 647 500.0 220.0 1390.0 343.8 78.9 0.56
V2 584 500.0 180.0 1790.0 378.5 89.2
V3 628 655.0 180.0 1020.0 261.9 65.5
TIMP-1 [ng/ml] V1 157 160.0 70.0 260.0 52.7 12.1 0.063
V2 173 170.0 100.0 260.0 40.8 9.6
V3 174 175.0 110.0 220.0 29.7 7.4
TIMP-2 [ng/ml] V1 129 120.0 75.0 285.0 45.3 10.4 0.012
V2 139 135.0 95.0 215.0 36.3 8.6
V3 149 137.5 90.0 220.0 38.3 9.6
Adiponectin [ng/ml] V1 15201 11890.0 3780.0 37970.0 8860.0 2032.6 0.0004
V2 13966 13020.0 3740.0 24990.0 6432.4 1516.1
  V3 19373 17190.0 8010.0 38550.0 8657.4 2164.4  
  1. p-value for the Friedman ANOVA test, Group 2, n=20.